Xeljanz 5 MG tablet UU 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F9LH4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,153
Award facts
- Contract value 100% obligated
- $13,153.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order award from the Defense Logistics Agency (DLA) on January 15, 2026, with an ultimate completion date of January 16, 2026. The contract, valued at $13,153.49 under firm fixed-price terms, covers the supply of Xeljanz 5 mg tablets (60-count units). This is a competitively awarded, non-set-aside contract with performance at the awardee's Conshohocken, Pennsylvania facility. The delivery order is issued under a larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical, a $999.99 billion prime contract running through December 2026 that serves as the comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, supplying an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The company's federal contracting demonstrates substantial capability in fulfilling competitive procurement requirements, with this delivery order representing a routine pharmaceutical supply transaction within its established relationship with the DLA medical supply chain serving Department of Defense healthcare customers globally.
Quick answers
Who was awarded contract SPE2DR26F9LH4?
SPE2DR26F9LH4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F9LH4 worth?
The government has obligated $13,153 on SPE2DR26F9LH4.
Is contract SPE2DR26F9LH4 an order under another contract?
Yes. SPE2DR26F9LH4 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9LH4 competed?
The extent of competition for SPE2DR26F9LH4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award